Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway. Trewin-Nybraten CB, Leithe S, Paulsen T, Langseth H, et al. Br J Cancer 2025 Apr 26. doi: 10.1038/s41416-025-03018.

Read + Share

Amedeo Smart

Independent Medical Education

Trewin-Nybraten CB, Leithe S, Paulsen T, Langseth H, et al. Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway. Br J Cancer 2025 Apr 26. doi: 10.1038/s41416-025-03018.
PMID: 40287590